MedPath

Pacing in Cardiac Magnetic Resonance Imaging: a CRT trial

Completed
Conditions
chronic heart failure
10019280
Registration Number
NL-OMON47190
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Patients need to fulfil the 2013 guideline of the European Society of Cardiology criteria for cardiac pacing and cardiac resynchronisation therapy. In order to participate in this study, a subject must meet all of the following criteria:
- Chronic heart failure
- New York Heart Association (NYHA) functional class II, III or ambulant IV
- QRS duration * 120ms
- Left bundle branch block
- Optimal pharmacological therapy
- LV ejection fraction * 35%
- Sinus rhythm

Exclusion Criteria

The exclusion criteria applying for this study are:
- Age <18 or incapacitated adult
- Significant rhythm abnormalities (irregularity by atrial fibrillation or frequent extrasystole)
- Artificial heart valves
- Pacemaker dependency

The exclusion criteria regarding CMR are:
- Lactation
- Documented allergic reaction to gadolinium
- Subjects with severely impaired renal function (GFR < 30 ml/min/1.73m2)
- Impossibility to undergo a MRI scan (determined by using the standard contraindications
for MR imaging as used for clinical purposes)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter is CMR cine image quality, quantified by grading 17 LV<br /><br>segments on a 5-point grading scale (grade 1 is excellent and 5<br /><br>non-diagnostic). Image quality will be compared post- versus pre-implantation.<br /><br>Quantitative LV functional and volumetric CMR parameters will be determined<br /><br>during intrinsic rhythm and during biventricular stimulation, this will be<br /><br>compared to pre-implantation CMR measurements (intrinsic rhythm) and invasive<br /><br>measurements (biventricular stimulation). </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath